NRNP 6549 Week 9 Confidential Adolescent Visit Example

Advanced Primary Care of Adolescents and Children Walden University Free custom sample in 24 to 48h

This NRNP 6549 Week 9 confidential adolescent visit note example records an annual visit for a composite 15-year-old tenth grader with migraine with aura who asks about contraception once her mother steps out. The note states the limits of confidentiality before anything else, then works through HEADSSS domain by domain. The contraception conversation explains why estrogen-containing methods are not suitable with aura under the CDC Medical Eligibility Criteria and discusses progestin-only and intrauterine options. Screening offered and accepted is recorded, the note says what stays private, and it records what the parent hears. Walden NRNP 6549, Advanced Primary Care of Adolescents and Children, grades confidentiality in MSN student notes as documentation, not intention. Sources include the US MEC, AAP guidance on adolescent confidentiality and the HEADSSS assessment.

CourseNRNP 6549 Advanced Primary Care of Adolescents and Children
WeekWeek 9
Paper typeConfidential adolescent visit note
LengthAbout 830 words, 6 pages
FormatAPA 7 student paper
SchoolWalden University
ProgramMaster of Science in Nursing (MSN)
UpdatedOctober 2026

Free sample paper for NRNP 6549 Week 9

1

Confidential Adolescent Visit Note: A 15-Year-Old With Migraine With Aura Asking About Contraception

Student Name

College of Nursing, Walden University

NRNP 6549: Advanced Primary Care of Adolescents and Children

Instructor Name

Month Day, Year

What this page is doingThe title names the one medical fact that changes the contraception conversation. Counseling in this note is graded on safety reasoning, and a reader who sees "migraine with aura" in the title already knows which methods the eligibility criteria will rule out.
2

Confidential Adolescent Visit Note: A 15-Year-Old With Migraine With Aura Asking About Contraception

Limits Stated Before Anything Else

Composite case. Annual health supervision visit for a 15-year-old girl in tenth grade, accompanied by her mother.

At the start of the visit, with both present, the clinician explained: that part of every visit from age 12 onward is spent with the adolescent alone; that what she says in that time stays between her and the clinician; and that the limits are a risk of serious harm to herself, a risk of serious harm to someone else, or abuse, in which case others would need to be told, and she would be told first. Her mother said she understood and agreed. The Society for Adolescent Medicine's position is that confidentiality should be explained to both adolescent and parent, including its limits, because adolescents are more likely to disclose and seek care when they trust it will be kept (Ford et al., 2004).

Time alone with the adolescent: 14 minutes, 10:22 to 10:36.

What this page is doingConfidentiality is documented as what was explained, to whom, and with which limits, with the time alone recorded. A note that only called the visit confidential could not be checked.
3

HEADSSS, Domain by Domain

The interview followed the HEADSSS sequence, which moves from less to more sensitive topics (Cohen et al., 1991).

Home: lives with her mother and younger brother; parents divorced, sees her father every other weekend. "My mom and I fight about my phone, but it's fine."

Education: tenth grade, mostly Bs, one C in chemistry. No absences beyond illness. Plans to study nursing or physical therapy.

Activities: varsity volleyball; works Saturday shifts at a bakery; two close friends.

Drugs: has tried alcohol twice at parties, no binge episodes described; no vaping, cannabis, or other drugs. Friends vape.

Sexuality: attracted to boys. Has had a boyfriend, 16, for four months. They have not had intercourse but have talked about it; she wants contraception "before, not after."

Suicide and depression: PHQ-9 score 3; answered "not at all" to thoughts of death or self-harm. Sleep about 7 hours on school nights.

Safety: seat belt always; boyfriend has never pressured her, hit her, or checked her phone; "he's actually really nice about it." No history of unwanted sexual contact.

The Contraception Conversation

Medical history relevant to contraception: headaches about twice a month since age 13. She describes a zigzag shimmering line in her vision that grows over about 20 minutes and then clears, followed by a throbbing one-sided headache with nausea. This is migraine with aura, documented in her chart by her previous clinician. Blood pressure today 108/66. No personal or family history of blood clots. Nonsmoker.

Options were discussed by category, with safety reasoning taken from the CDC's 2024 eligibility criteria for contraceptive methods, the U.S. MEC (Nguyen et al., 2024). Methods containing estrogen, including the pill, patch, and ring, sit in category 4 for anyone with migraine with aura, meaning they should not be used, since estrogen adds to the stroke risk that aura already carries; they were not offered. Progestin-only methods, the implant, the injection, and progestin-only pills, carry no restriction for migraine with aura. Both types of intrauterine device carry no restriction for migraine; for users younger than 20, they are category 2, meaning the benefits generally outweigh the risks. Condoms were discussed for infection prevention with any method.

She chose the implant after discussing bleeding changes, which are the most common reason for removal. Placement was scheduled for next week, with a pregnancy test at that visit; condoms were provided today. Emergency contraception was explained and a prescription given in case it is needed before placement.

Screening Offered and Accepted

Offered: urine nucleic acid amplification test for chlamydia and gonorrhea, and an HIV test. She accepted both, understanding she is not yet sexually active; the tests establish a baseline and will be repeated once she is. HPV vaccination: series complete per record.

What Stays Private

CONFIDENTIAL, not for parent communication: her relationship, the contraception discussion and implant plan, the alcohol use, the screening tests and results. Portal and billing: her mother has proxy access to the patient portal. The implant visit, the prescription for emergency contraception, and the laboratory results could appear there or on an explanation of benefits sent to the policyholder, her mother. Actions taken: the visit was flagged as confidential in the record, the laboratory results were set to adolescent-only release, and she chose to pay the pharmacy directly for the emergency contraception. The implant visit may still appear on the insurer's statement; she was told this plainly and said she will think about whether to tell her mother before next week.

What this page is doingThe private section is boxed and lists exactly what is withheld, then names the portal and billing routes that could expose it and what was done about each. This is where confidentiality most often fails in practice.
4

What the Parent Hears

With her daughter's agreement, her mother was told: the physical exam was normal; her daughter's growth and blood pressure are healthy; her migraines are the kind that come with visual changes, which matters for some medicines in the future, and she should not start any estrogen-containing medicine without checking with the clinic; she is doing well at school and sleeping enough; and she should come back in one year, or sooner for headaches that change in pattern.

References

Cohen, E., Mackenzie, R. G., & Yates, G. L. (1991). HEADSS, a psychosocial risk assessment instrument: Implications for designing effective intervention programs for runaway youth. Journal of Adolescent Health, 12(7), 539-544. https://doi.org/10.1016/0197-0070(91)90084-Y

Ford, C., English, A., & Sigman, G. (2004). Confidential health care for adolescents: Position paper of the Society for Adolescent Medicine. Journal of Adolescent Health, 35(2), 160-167. https://doi.org/10.1016/j.jadohealth.2004.03.002

Nguyen, A. T., Curtis, K. M., Tepper, N. K., Kortsmit, K., Brittain, A. W., Snyder, E. M., Cohen, M. A., Zapata, L. B., & Whiteman, M. K. (2024). U.S. medical eligibility criteria for contraceptive use, 2024. MMWR Recommendations and Reports, 73(4), 1-126. https://doi.org/10.15585/mmwr.rr7304a1

Reading the NRNP 6549 Week 9 instructions

Week 9 of NRNP 6549 often asks for a note on a confidential adolescent visit. You document how confidentiality and its limits were explained, conduct a psychosocial assessment such as HEADSSS, address the adolescent's concern with evidence-based options, offer recommended screening, and record exactly which parts the parent will hear. Faculty grade the documentation of confidentiality itself. Cite the US MEC, AAP guidance and the assessment tool in APA 7. State minor consent laws may be relevant and are often mentioned briefly. The plan should respect the adolescent's choices. Safety concerns that require disclosure should be defined. NRNP 6549 faculty want the confidentiality script recorded in substance, along with when the parent left the room. Each HEADSSS domain needs a finding, even if negative. State which screens were offered and accepted.

Inside the NRNP 6549 Week 9 example

The note begins with a documented statement that confidentiality and its limits were explained to the adolescent and her mother together, then records the time the adolescent was seen alone. The psychosocial section follows HEADSSS in its usual order, home, school or work, activities, drugs, sexuality, mood and suicide risk, and safety, with one or two plain sentences under each, some quoting her. She reports a new relationship and asks about contraception. That conversation is summarized with the options discussed by category and the CDC's US Medical Eligibility Criteria for Contraceptive Use cited for the safety reasoning. Screening offered and accepted is recorded. A boxed section marks what is confidential. A shorter section, written for the parent, covers only what the adolescent agreed to share, and a line flags portal and billing settings that could expose the rest.

Where the marks sit in the NRNP 6549 Week 9 rubric

Confidentiality is graded as documentation, not as good intentions. A note that calls the visit confidential without recording what was explained, to whom, and with which limits cannot be checked, and the example records all three. The psychosocial criterion looks for every HEADSSS domain addressed, and skipping suicide and depression screening to spare an awkward moment is a serious deduction in most sections. Counseling is judged on whether the reasoning cites an eligibility standard rather than personal preference. Points also fall away when the parent summary repeats confidential content, when screening is described without consent being recorded, or when follow-up leaves the adolescent no private way to return. Citation currency matters: guidance on adolescent reproductive care is revised, and older editions are noticed.

NRNP 6549 Week 9 help from the desk

Adolescent notes lose credit when they call the visit confidential without recording what was explained and to whom. Write it down. Another common gap is offering a combined pill to a patient with migraine with aura, which the MEC rates as unacceptable risk. Check the category. Writers also skip HEADSSS domains such as safety or suicidality. Cover each one. Avoid leaving the parent's part of the visit undocumented. Record what the parent was told. Name the conditions under which confidentiality would be broken. Close with follow-up and how the adolescent can reach the clinic privately. Writers also forget to say how test results will reach her privately. Arrange it. Another frequent slip is ignoring the aura history when choosing contraception. Record when it began and what it looks like.

Get a NRNP 6549 Week 9 example written to your instructions

With your Week 9 prompt and rubric in hand, the desk writes an adolescent visit note to your section's case, confidential and parent-facing sections kept apart. If your prompt names a different psychosocial framework, say so and the note follows it. You receive it within 24-48 hours, and the first one carries no charge.

More NRNP 6549 papers and MSN samples

NRNP 6549 Week 9 questions, answered

What does HEADSSS stand for in the note?

Home, education and employment, activities, drugs, sexuality, suicide and depression, and safety. The example uses it as the skeleton of the psychosocial section, since working through it in sequence shows that no area was passed over. If your program teaches a different or expanded version, the note follows that one, and the documentation discipline stays exactly the same.

Would the note ever break confidentiality?

It states the limits at the start: risk of serious harm to the adolescent or someone else, and abuse, where a report is required. In this composite nothing crosses those lines, so nothing is shared beyond what she agreed to. Where a case does cross them, the note documents the concern and the required report; the example does not model procedure beyond that.

Do state laws on minor consent appear in the note?

The note records that consent for the services discussed was obtained under the rules that apply where the visit took place, without naming a state, because those rules differ. A write-up for your section would cite whatever law or policy your program points you to. The sixteen-year-old herself is a composite, invented for the page and drawn from no real visit.

Where can I find a free NRNP 6549 Week 9 sample paper?

The 15-year-old's confidential visit note is shown here with the stated limits, HEADSSS by domain, the contraception conversation and what the parent hears.

Which contraception is unsuitable in NRNP 6549 Week 9?

Methods with estrogen, because she has migraine with aura; progestin-only and intrauterine options are discussed instead.